PNC FINANCIAL SERVICES GROUP, INC. - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 168 filers reported holding ASCENDIS PHARMA A/S in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.6%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$1,519,309
+8.0%
16,225
+2.9%
0.00%0.0%
Q2 2023$1,407,295
-5.2%
15,768
+13.9%
0.00%0.0%
Q1 2023$1,484,676
-1.3%
13,847
+12.4%
0.00%0.0%
Q4 2022$1,504,763
+16.3%
12,321
-1.8%
0.00%0.0%
Q3 2022$1,294,000
+24.9%
12,541
+12.6%
0.00%0.0%
Q2 2022$1,036,000
-0.8%
11,134
+25.2%
0.00%0.0%
Q1 2022$1,044,000
-19.4%
8,894
-7.7%
0.00%0.0%
Q4 2021$1,296,000
-12.5%
9,632
+3.6%
0.00%0.0%
Q3 2021$1,481,000
+41.5%
9,293
+16.9%
0.00%0.0%
Q2 2021$1,047,000
+9.5%
7,950
+7.2%
0.00%0.0%
Q1 2021$956,000
+8.1%
7,416
+40.0%
0.00%0.0%
Q4 2020$884,000
-3.3%
5,299
-10.5%
0.00%0.0%
Q3 2020$914,000
+2.0%
5,922
-2.4%
0.00%0.0%
Q2 2020$896,000
+28.2%
6,066
-2.2%
0.00%0.0%
Q1 2020$699,000
-13.8%
6,204
+6.6%
0.00%0.0%
Q4 2019$811,000
+45.1%
5,822
+0.2%
0.00%0.0%
Q3 2019$559,000
-13.2%
5,811
+3.7%
0.00%0.0%
Q2 2019$644,000
+51.2%
5,603
+54.8%
0.00%
Q1 2019$426,000
+5.4%
3,620
-43.8%
0.00%
Q4 2018$404,000
-15.8%
6,440
-4.7%
0.00%
Q3 2018$480,000
+37.1%
6,760
+28.5%
0.00%
Q2 2018$350,0005,2600.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q1 2023
NameSharesValueWeighting ↓
RA Capital Management 11,225,357$1,001,863,11218.92%
Q Global Advisors, LLC 195,000$17,40412.55%
Sofinnova Investments, Inc. 754,032$67,297,3564.41%
Avoro Capital Advisors LLC 3,580,555$319,564,5344.34%
Finepoint Capital LP 139,772$12,474,6514.32%
Spyglass Capital Management LLC 657,853$58,713,3804.24%
Saturn V Capital Management LP 78,442$7,000,9483.88%
DAFNA Capital Management LLC 135,212$12,067,6713.30%
ARS Investment Partners, LLC 289,860$25,870,0053.02%
Ghost Tree Capital, LLC 100,000$8,925,0002.95%
View complete list of ASCENDIS PHARMA A/S shareholders